<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Springer Science and Business Media LLC</publisher>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2018-01-06">2018-01-06</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Cava</surname></persName>
							<idno type="ORCID">0000-0002-5540-4104</idno>
						</author>
						<author>
							<persName><forename type="first">Gloria</forename><surname>Bertoli</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Antonio</forename><surname>Colaprico</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Catharina</forename><surname>Olsen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Gianluca</forename><surname>Bontempi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Isabella</forename><surname>Castiglioni</surname></persName>
						</author>
						<title level="a" type="main">Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis</title>
					</analytic>
					<monogr>
						<title level="j" type="main">BMC Genomics</title>
						<title level="j" type="abbrev">BMC Genomics</title>
						<idno type="eISSN">1471-2164</idno>
						<imprint>
							<publisher>Springer Science and Business Media LLC</publisher>
							<biblScope unit="volume">19</biblScope>
							<biblScope unit="issue">1</biblScope>
							<date type="published" when="2018-01-06" />
						</imprint>
					</monogr>
					<idno type="MD5">775FA067D7A611542BA7A040D5A7F022</idno>
					<idno type="DOI">10.1186/s12864-017-4423-x</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T13:07+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experiment title:</head><p>Brain tumor irradiative therapies and related mRNA and miRNA: a window on potential differential genic and epigenetic responses to MRT </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>The working hypothesis of the present project is based on an already published data <ref type="bibr" target="#b0">(Bouchet et al., 2013)</ref>. In this paper the authors matched the gene expression profile of normal brain, before and after MRT radiation (400Gy, 50 micron wide, 211 micron center to center; 10Gy dose valley), and of brain injected with 9L glioblastoma tumor cells, at the level of caudatum nucleus, before and after radiation. The comparison between brain sample before and after MRT revealed how many and which genes are differentially expressed due to MRT in the normal tissue (DEGs brain + MRT, DEGs: Differential Expressed Genes); the comparison between glioblastoma cells before and after MRT revealed how many and which genes of the glioblastoma are differentially expressed and are affected by MRT (DEGs 9L + MRT).</p><p>Here, we considered those genes of the glioblastoma which are affected by MRT radiation (n=16 DEGs 9L+MRT). We found that three of these 16 genes are connected by physical interaction, namely PLK1, CCNB1 and CDC20. Looking for validated miRNAs able to control these 16 DEGs, we found 44 miRNAs regulating 8 DEGs of the 16 DEGs 9L+MRT. Three miRNAs of the 44 (namely, miR-215-5p, miR-192-5p and miR-335-5p) have a higher degree centrality (HDC), being degree centrality the capability of a miRNA to regulate more than one target <ref type="bibr" target="#b1">(Cava et al., 2018)</ref>; these three miRNAs are indeed able to control 3 DEGs, as depicted in the figure <ref type="figure">1</ref>. Further investigation are required to: 1. validate the identified miRNAs in glioblastoma tumors before and after MRT, in order to understand if they are possible 'responders' to MRT 2. understand the role of these miRNAs within the selected network 3. understand which pathways could be involved in MRT effect in glioblastoma tumors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Validation procedure</head><p>Total RNA of tissue samples (n=26) will be isolated using Trireagent reagent (Sigma) following the manufacturer's recommendations. For serum samples (n=26), miRNeasy Serum/Plasma Kit will be used following manufacturer's recommendation. For miRNA quantification, the obtained RNA will be reverse transcribed using MystiCq microRNA cDNA synthesis kit (Sigma Aldrich), following manufacturer's recommendations. miRNAs will be amplified in Eco real time-PCR (RT-PCR) (Illumina, Euroclone) using Power Up Sybr green mix (Applied Biosystem) in combination with homemade designed primers. miRNAs will be selected by in silico analysis of public databases (i.e. GSE50478) containing information on gene expression profile of normal brain before and after MRT radiation and of brain injected with 9L glioblastoma tumor cells, at the level of caudatum nucleus, before and after radiation. miRNAs able to control differentially expressed genes of glioblastoma as a response to MRT treatment will be selected and analysed in our samples by RT-PCR.</p><p>Figure <ref type="figure">1</ref>: schematic representation of the network created between 8 connected DEGs, altered by MRT in glioblastoma tumors, and their related miRNAs, regulating those DEGs. In green, miRNAs with higher degree centrality (HDC) are highlighted.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Names and affiliations of applicants(* indicates experimentalists): Gabriele E. M. Biella1*, Antonio G. Zippo1*, Gloria Bertoli1*, Paola Coan3*, Alberto Bravin2* 1. Institute of Molecular Bioimaging and Physiology, Consiglio Nazionale delle Ricerche, Milan, Italy 2. European Synchrotron Radiation Facility, Grenoble, France 3. Ludwig-Maximillian University, Munich, Germany</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="3,63.78,216.23,473.42,355.05" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Early Gene Expression Analysis in 9L Orthotopic Tumor-Bearing Rats Identifies Immune Modulation in Molecular Response to Synchrotron Microbeam Radiation Therapy</title>
		<author>
			<persName><forename type="first">Audrey</forename><surname>Bouchet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nathalie</forename><surname>Sakakini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michèle</forename><surname>El Atifi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Céline</forename><surname>Le Clec'h</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Elke</forename><surname>Brauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anaïck</forename><surname>Moisan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pierre</forename><surname>Deman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pascal</forename><surname>Rihet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Géraldine</forename><surname>Le Duc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Laurent</forename><surname>Pelletier</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0081874</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">e81874</biblScope>
			<date type="published" when="2013-12-31">2013</date>
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Bouchet A, Sakakini N, El Atifi M, Le Clec&apos;h C, Brauer E, Moisan A, et al. Early gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapy. PLoS One. 2013;8(12):e81874.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis</title>
		<author>
			<persName><forename type="first">Claudia</forename><surname>Cava</surname></persName>
			<idno type="ORCID">0000-0002-5540-4104</idno>
		</author>
		<author>
			<persName><forename type="first">Gloria</forename><surname>Bertoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Antonio</forename><surname>Colaprico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Catharina</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gianluca</forename><surname>Bontempi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Isabella</forename><surname>Castiglioni</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12864-017-4423-x</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Genomics</title>
		<title level="j" type="abbrev">BMC Genomics</title>
		<idno type="ISSNe">1471-2164</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">25</biblScope>
			<date type="published" when="2018-01-06">2018 Jan 6</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Cava C, Bertoli G, Colaprico A, Olsen C, Bontempi G, Castiglioni I. Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis. BMC Genomics. 2018 Jan 6;19(1):25. doi: 10.1186/s12864-017-4423-x.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
